Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Conditions: Grade I Meningioma; Grade II Meningioma; Grade III Meningioma; Recurrent Meningioma; Unresectable Meningioma Interventions: Radiation: Gallium Ga 68-DOTATATE; Drug: Lutetium Lu 177 Dotatate; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials